Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

153 та иш

Иш: Artificial intelligence for chimeric antigen receptor-based therapies: a comprehensive review of current applications and future perspectives

  1. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository

    Kenneth Clark, Bruce A. Vendt, Kirk Smith +9

    Мақола20138 иқтибос
    ABI

  2. Principles of early drug discovery

    J. P. HUGHES, S. Rees, S. Barret Kalindjian +1

    Шарҳ мақола20106 иқтибос
    ABI

  3. Machine Learning in Medicine

    Alvin Rajkomar, Jay B. Dean, Isaac S. Kohane

    Шарҳ мақола20195 иқтибос
    ABI

  4. A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

    Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai +18

    Мақола20173 иқтибос
    ABI

  5. CRISPR/Cas9-mediated PD-1 disruption enhances human mesothelin-targeted CAR T cell effector functions

    Wanghong Hu, Zhenguo Zi, Yanling Jin +5

    Мақола20183 иқтибос
    ABI

  6. Artificial intelligence in radiology

    Ahmed Hosny, Chintan Parmar, John Quackenbush +2

    Шарҳ мақола20183 иқтибос
    ABI

  7. Artificial intelligence in cancer imaging: Clinical challenges and applications

    Wenya Linda Bi, Ahmed Hosny, Matthew B. Schabath +16

    Шарҳ мақола20193 иқтибос
    ABI

  8. Study on artificial intelligence: The state of the art and future prospects

    Caiming Zhang, Yang Lu

    Мақола20213 иқтибос
    ABI

  9. Artificial intelligence assists precision medicine in cancer treatment

    Jinzhuang Liao, Xiaoying Li, Yu Gan +5

    Шарҳ мақола20233 иқтибос
    ABI

  10. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

    Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles +28

    Мақола20163 иқтибос
    ABI

  11. Radiomics: the bridge between medical imaging and personalized medicine

    Philippe Lambin, Ralph T. H. Leijenaar, Timo M. Deist +17

    Шарҳ мақола20173 иқтибос
    ABI

  12. Development and validation of three machine-learning models for predicting multiple organ failure in moderately severe and severe acute pancreatitis

    Qiu Qiu, Yongjian Nian, Yan Guo +6

    Мақола20193 иқтибос
    ABI

  13. International evaluation of an AI system for breast cancer screening

    Scott Mayer McKinney, Marcin Sieniek, Varun Godbole +28

    Мақола20203 иқтибос
    ABI

  14. Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?

    Reid F. Thompson, Gilmer Valdés, Clifton D. Fuller +10

    Шарҳ мақола20182 иқтибос
    ABI

  15. Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer

    Amanda Rosewell Shaw, Caroline E. Porter, Norihiro Watanabe +5

    Мақола20172 иқтибос
    ABI

  16. CAR T cells in solid tumors: challenges and opportunities

    Faroogh Marofi, Roza Motavalli, В. А. Сафонов +12

    Шарҳ мақола20212 иқтибос
    ABI

  17. Artificial Intelligence in Cancer Research: Trends, Challenges and Future Directions

    Anu Maria Sebastian, David Peter

    Шарҳ мақола20222 иқтибос
    ABI

  18. Protecting Your Patients’ Interests in the Era of Big Data, Artificial Intelligence, and Predictive Analytics

    Patricia Balthazar, Peter A. Harri, Adam Prater +1

    Мақола20182 иқтибос
    ABI

  19. Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

    Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González +30

    Мақола20172 иқтибос
    ABI

  20. Radiomics: Extracting more information from medical images using advanced feature analysis

    Philippe Lambin, Emmanuel Rios-Velazquez, Ralph T. H. Leijenaar +8

    Шарҳ мақола20122 иқтибос
    ABI

  21. In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy

    Sean P. Arlauckas, Christopher Garris, Rainer H. Köhler +9

    Мақола20172 иқтибос
    ABI

  22. From machine learning to deep learning: progress in machine intelligence for rational drug discovery

    Lu Zhang, Jianjun Tan, Dan Han +1

    Шарҳ мақола20172 иқтибос
    ABI

  23. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

    Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel +26

    Мақола20182 иқтибос
    ABI

  24. Next generation of immune checkpoint therapy in cancer: new developments and challenges

    Julian A. Marin‐Acevedo, Bhagirathbhai Dholaria, Aixa Soyano +3

    Шарҳ мақола20182 иқтибос
    ABI

  25. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors

    Satya Das, Douglas B. Johnson

    Шарҳ мақола20192 иқтибос
    ABI